Stiff, Patrick J <br/><br/>
The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Aug 2003 
 - 529-39 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1083-8791 
<br/><br/><label>Standard No.: </label>10.1016/s1083-8791(03)00205-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Bone Marrow Transplantation--adverse effects<br/>Carmustine--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Disease Management<br/>Etoposide--administration & dosage<br/>Female<br/>Hodgkin Disease--complications<br/>Humans<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Proportional Hazards Models<br/>Salvage Therapy--methods<br/>Survival Analysis<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Autologous<br/>Whole-Body Irradiation